TAC1 and Alzheimer disease: Similarly, in Alzheimer’s disease, reduced levels of substance P are observed in the cortical regions of postmortem brain tissues and in patient cerebrospinal fluid (Quigley and Kowall, 1991; Kowall et al., 1993; Waters and Davis, 1997; Raffa, 1998).